In this CAPcast, we’ll speak with Diane Cardona, MD, FCAP, Chair of the Quality and Clinical Data Registry Affairs Committee, about why eligible pathologists should consider MIPS participation as a strategy to help protect revenues as well as a strategy to demonstrate their value instead of seeking a COVID exemption.
